# SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue

> **NCT06987370** · NA · RECRUITING · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 90 (estimated)

## Conditions studied

- Bone Metastases in Subjects With Advanced Cancer

## Interventions

- **RADIATION:** Conventional Radiotherapy (CRT)
- **RADIATION:** SCART (Stereotactic Central Ablative Radiation Therapy ) /SFRT（Spatially Fractionated Radiation Therapy ）

## Key facts

- **NCT ID:** NCT06987370
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2027-11-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06987370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06987370, "SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06987370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*